Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 12, 2023, titled "Ichnos Sciences Enters Licensing Agreement For OX40 Antagonist Monoclonal Antibody Portfolio with Astria Therapeutics".
Glenmark Pharmaceuticals Limited Press Release Oct 12 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Press Release Sep 27 2023
- Press Release Sep 21 2023
- Press Release Aug 17 2023
- Press Release Aug 01 2023
- Press Release May 19 2023
Later from Glenmark Pharmaceuticals
- Glenmark Pharmaceuticals Limited Press Release Oct 17 2023
- Press Release Oct 18 2023
- Glenmark Pharmaceuticals Limited Press Release Nov 07 2023
- Press Release Nov 10 2023
- Glenmark Pharmaceuticals Limited Press Release Jan 03 2024
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals